SKI Market

Indian Indices

Sensex

81,666.46 943.52
( 1.17%)

Global Indices

Nasdaq

49,433.27 519.79
(1.06%)

Dow Jones

6,997.90 37.87
(0.54%)

Hang Seng

52,813.31 -509.54
(-0.96%)

Nikkei 225

10,322.91 99.37
(0.97%)

Forex

USD-INR

91.66 -0.27
(-0.29%)

EUR-INR

108.61 -1.36
(-1.24%)

GBP-INR

125.41 -1.53
(-1.21%)

JPY-INR

0.59 -0.01
(-1.35%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Wockhardt Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532300

INE049B01025

177.6237045

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

WOCKPHARMA

151.47

21363.66

EPS(TTM)

Face Value()

Div & Yield %

8.68

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	1402.00	1154.00	1072.00	1372.00	987.00	890.06
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1402.00	1154.00	1072.00	1372.00	987.00	890.06
Other Income	55.00	41.00	67.00	38.00	1026.00	137.58
Stock Adjustments	46.00	-14.00	-30.00	-2.00	2.00	8.61
Total Income	1503.00	1181.00	1109.00	1408.00	2015.00	1036.25
EXPENDITURE :
Raw Materials	482.00	447.00	371.00	474.00	418.00	321.90
Power & Fuel Cost	75.00	68.00	54.00	62.00	55.00	61.02
Employee Cost	262.00	247.00	240.00	261.00	293.00	325.46
Other Manufacturing Expenses	71.00	71.00	60.00	94.00	86.00	54.39
Selling & Administrative Expenses	180.00	179.00	178.00	181.00	166.00	180.29
Miscellaneous Expenses	78.00	178.00	304.00	76.00	251.00	88.75
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1148.00	1190.00	1207.00	1148.00	1269.00	1031.81
Operating Profit	355.00	-9.00	-98.00	260.00	746.00	4.44
Interest	199.00	237.00	229.00	273.00	200.00	220.17
Gross Profit	156.00	-246.00	-327.00	-13.00	546.00	-215.73
Depreciation	168.00	176.00	186.00	171.00	184.00	173.39
Profit Before Tax	-12.00	-422.00	-513.00	-184.00	362.00	-389.12
Tax	0.00	0.00	0.00	5.00	-136.00	-47.11
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	-47.00	-49.00	-95.00	-110.89
Reported Net Profit	-12.00	-422.00	-466.00	-140.00	593.00	-231.12
Extraordinary Items	0.00	-14.00	-235.00	0.00	-142.00	94.56
Adjusted Net Profit	-12.00	-408.00	-231.00	-140.00	735.00	-325.68
Adjustment below Net Profit	0.00	0.00	4.00	-1.00	0.00	3.81
P & L Balance brought forward	-890.00	-468.00	-3.00	138.00	-125.00	103.08
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	330.00	0.00
P & L Balance carried down	-902.00	-890.00	-465.00	-3.00	138.00	-124.23
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-0.74	-27.40	-32.36	-9.72	53.91	-20.87
Earnings Per Share(Adj)-Unit Curr	-0.74	-27.40	-32.36	-9.72	49.68	-19.23
Book Value-Unit Curr	170.56	116.62	121.74	153.61	146.00	89.82
Book Value(Adj)-Unit Curr	170.56	116.62	121.74	153.61	134.54	82.77

81,666.46 943.52 ( 1.17%)

49,433.27 519.79 (1.06%)

6,997.90 37.87 (0.54%)

52,813.31 -509.54 (-0.96%)

10,322.91 99.37 (0.97%)

91.66 -0.27 (-0.29%)

108.61 -1.36 (-1.24%)

125.41 -1.53 (-1.21%)

0.59 -0.01 (-1.35%)